fashion -WSS

fashion

author：hotspot 2025-08-12 09:11:57 - browse：4915

A handout illustration representing Google’s DeepMind subsidiary and Isomorphic Labs developed an AI model that can accurately predict how a vast universe of biomolecules interact on an atomic level. — DeepMind

Google on Wednesday unveiled an artificial intelligence tool capable of predicting the structure and interaction of a vast universe of biomolecules, a fundamental advance that may help scientists unravel poorly understood aspects of biology and disease.

The new AI, dubbed AlphaFold 3, improves upon earlier versions of the model by predicting not just the structure of proteins, but all the molecules that interact with them in cells, including RNA, DNA, ions, and other small molecules.

Most new drugs consist of small molecules designed to bind to a protein involved in disease. AlphaFold 3 opens broader avenues of exploration, allowing scientists to rapidly examine complex interactions with other molecules that may highlight new disease targets — and different ways of attacking them.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Startling documents reveal new facets of Sacklers' opioid empire

WSS

Dark money group runs ads on China biotech bill

Biogen Alzheimer’s drug launch off to slow start

Antibiotic resistance nearly killed me, so I'm raising awareness of it

BioAge raises $170M for combination therapy with Zepbound

Biden report: The neurospychology of memory and aging

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

knowledge

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

The high cost of giving birth even with insurance

The dental labor crisis is a moment of opportunity

What does generative AI mean for health care? We asked experts

Why did Pfizer dish out millions for a Super Bowl ad?

At least 13 dead in Texas as scorching temps continue

'Revelatory' study finds a smoking impact that remains after quitting

New air purifier tech could be key to improving indoor air quality

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Virginia high school admissions case could be legal follow

Biohaven protein

focus

Medicare Advantage proposed rates disappoint insurers

Do more moles mean more problems? Not so, says new study

Focused ultrasound for uterine fibroids: an uphill battle

Dark money group runs ads on China biotech bill

Senators start work on Medicare physician payment reform

Antibiotic resistance nearly killed me, so I'm raising awareness of it

hotspot

Wikipedia

leisure time

entertainment